Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03667404 · ClinicalTrials.gov registry record · Phase 2

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

A Phase 2 study of Parkinson Disease and Dietary Modification, sponsored by Northwestern University.

Active
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT03667404 is a Phase 2 study of Parkinson Disease and Dietary Modification that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 30 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03667404, a Phase 2 study of Parkinson Disease and Dietary Modification, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the safety and tolerability of a dietary fiber, resistant maltodextrin, in people with Parkinson's disease. It will also evaluate the fiber's effect on the gut microbiome and potential effects on motor function and non-motor functions. Half of the participants will receive resistant maltodextrin and the other half will receive a control substance, maltodextrin.

Conditions Studied

Parkinson Disease Dietary Modification Intestinal Bacteria Flora Disturbance

Interventions

  • DIETARY_SUPPLEMENT Resistant maltodextrin
  • DIETARY_SUPPLEMENT maltodextrin

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-11-06
Est. Completion 2026-03-31
Phase Phase 2

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03667404

The ClinicalTrials.gov registry entry for NCT03667404 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Resistant maltodextrin is the first listed.

NCT03667404 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03667404 about?

NCT03667404 is a clinical study titled "Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study". This study will evaluate the safety and tolerability of a dietary fiber, resistant maltodextrin, in people with Parkinson's disease. It will also evaluate the fiber's effect on the gut microbiome and potential effects on motor function and non-motor functions. Half of the participants will receive r...

What is the current status of trial NCT03667404?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2018-11-06. Estimated completion is 2026-03-31.

What conditions does trial NCT03667404 study?

This clinical trial studies the following conditions: Parkinson Disease, Dietary Modification, Intestinal Bacteria Flora Disturbance.

What interventions are being tested in trial NCT03667404?

The interventions under investigation include: Resistant maltodextrin (DIETARY_SUPPLEMENT), maltodextrin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03667404?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03667404 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Dietary Modification

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.